EP 1360293 A2 20031112 - SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES
Title (en)
SEQUENCES INVOLVED IN PHENOMENA OF TUMOUR SUPPRESSION, TUMOUR REVERSION, APOPTOSIS AND/OR VIRUS RESISTANCE AND THEIR USE AS MEDICINES
Title (de)
SEQUENZEN DIE AN DER TUMORUNTERDRÜCKUNG, TUMORUMKEHRUNG, APOPTOSIS, UND/ODER VIRUSRESISTENZ BETEILIGT SIND, UND IHRE VERWENDUNG ALS ARZNEIMITTEL
Title (fr)
SEQUENCES IMPLIQUEES DANS LES PHENOMENES DE SUPPRESSION TUMORALE, REVERSION TUMORALE, APOPTOSE ET/OU RESISTANCE AUX VIRUS ET LEUR UTILISATION COMME MEDICAMENTS
Publication
Application
Priority
- FR 0200543 W 20020213
- FR 0101925 A 20010213
Abstract (en)
[origin: FR2820757A1] The invention concerns in particular novel sequences involved in the molecular pathways of tumour suppression, tumour reversion, apoptosis and/or virus resistance. The invention also concerns the use of said sequences for treatment against cancers, viral diseases, neurodegenerative diseases and in the field of diagnosis and for implementing screening methods for assay of compounds. The invention further concerns methods for detection and/or assay of sequences of the invention or their expression products in a biological sample.
IPC 1-7
C12N 15/12; C07K 14/47; C07K 16/18; C12N 15/63; C12N 15/10; C12Q 1/68; G01N 33/53; A61K 48/00; A61K 39/395; A61K 38/17; A61P 35/00; A61P 31/12; A61P 25/00; A01K 67/027
IPC 8 full level
A01K 67/027 (2006.01); C07K 14/47 (2006.01); A61K 31/7088 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); A61P 31/12 (2006.01); A61P 35/00 (2006.01); C07K 16/18 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/10 (2006.01); C12N 15/12 (2006.01); C12N 15/63 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)
CPC (source: EP US)
A61P 25/00 (2017.12 - EP); A61P 31/12 (2017.12 - EP); A61P 35/00 (2017.12 - EP); C07K 14/47 (2013.01 - EP US); A01K 2217/05 (2013.01 - EP US); C12N 2799/021 (2013.01 - EP US)
Citation (search report)
See references of WO 02064731A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
FR 2820757 A1 20020816; CA 2438219 A1 20020822; EP 1360293 A2 20031112; JP 2004532007 A 20041021; US 2005221303 A1 20051006; WO 02064731 A2 20020822; WO 02064731 A3 20030306; WO 02064731 A9 20040422; WO 02064731 B1 20030821
DOCDB simple family (application)
FR 0101925 A 20010213; CA 2438219 A 20020213; EP 02708409 A 20020213; FR 0200543 W 20020213; JP 2002565046 A 20020213; US 46785105 A 20050209